The goal is to deliver new technologies to doctors faster.
Cultivating fresh thinking and continual adaptation is key.
Market growth can be attributed to a healthy pipeline of science and medical research institutes.
The increase in communicable diseases is elevating competition in the device arena.
Via partnerships with pharmaceutical companies, Insulet expands its platform technology past insulin delivery.
Targeting this region could expedite your company’s growth.
Shift the odds in your favor.
The collaboration has resulted in a solution that aims to improve patient outcomes and reduce costs.
As the incidence of GI conditions grows, device companies in this segment should explore expansion in the region.
The move is expected to save as much as $1 billion.